Point mutations in the thyrotropin receptor in human thyroid tumors.
The mechanism of the impaired response to thyrotropin (TSH) in thyroid tumor cells was investigated by searching for structural changes in the TSH receptor (TSH-R) in neoplastic thyroid tissues in humans. Total RNA was prepared from 34 thyroid tissue samples (four normal, six adenoma, six follicular cancer, and 18 papillary cancer) and reverse- transcribed into single-stranded cDNA, which was then used as a template for the polymerase chain reaction and subjected to single-strand conformation polymorphism (SSCP) analysis. Two fragments, FRAG (468-692) (nucleotides 468 to 692, corresponding to the mid-portion of the receptor extracellular domain) and FRAG (2044-2295) (nucleotides 2044 to 2295, corresponding to the COOH-terminal, cytoplasmic domain of the TSH-R cDNA) showed differences in electrophoretic mobility among the various thyroid tissue samples. Direct sequencing revealed Phe197 (TTC) --> Ile(ATC), and Asp219 (GAT) --> Glu(GAG) substitutions in FRAG (468-692) from two papillary cancers. Three types of substitution were identified in FRAG(2044-2295): Asn715 (AAC) --> Asp(GAC) from one papillary cancer, Lys723 (AAG) --> Met(ATG) from one papillary cancer, and Asp 727 (GAC) --> Glu(GAG) from one normal tissue sample, one follicular cancer, and four papillary cancers. These results suggest that there exist structural changes in TSH-R in some cases of thyroid neoplastic tissue.